Megan Perrett^1*, Lucy Pickard, MB ChB^1*, Emil Kumar, MB BChir PhD^1*, Giuseppe Palladino, PhD^1*, Faraz Khan, PhD^2*, Carina Edmondson, PhD^1*, Connor Knight^2*, Edward Poynton^1*, Janet Matthews^1*, Shamzah Araf, MRCP, MBBS, PhD^1*, Andrew James Clear, BSc^1*, Maria Calaminici, MD, PhD^1*, John G. Gribben, MD, DSc, FRCPath³, Hamish King, PhD^4*, Mirjana Efremova, PhD^2*, Jun Wang, PhD^2* and Jessica Okosun, PhD¹

¹Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom
²Centre for Cancer Genomics and Computational Biology, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom
³Barts Cancer Institute, Queen Mary University of London, London, United Kingdom
⁴Epigenetics and Development, The Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia

Clementine Sarkozy, MD, PhD^1,2*, Shaocheng Wu^3*, Katsuyoshi Takata, MD, PhD^4*, Tomohiro Aoki, MD, PhD⁴, Susana Ben-Neriah, MSc^4*, Katy Milne^5*, Brad H Nelson^5*, Andrew P. Weng, MD⁶, David W. Scott, PhD, MD, FRACP, FRCPA^7,8, Jeffrey W. Craig, MD, PhD^9*, Christian Steidl^4,10* and Andrew Roth^3*

¹Institut Curie, Saint Cloud, France, Saint Cloud, France
²Hematology Department, Institut Curie, Saint Cloud, France
³BC Cancer, Department of Molecular Oncology, Vancouver, BC, Canada
⁴Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada
⁵Deeley Research Centre, BC Cancer, Victoria, BC, Canada
⁶Terry Fox Laboratory, BC Cancer Agency, Vancouver, BC, Canada
⁷Centre for Lymphoid Cancer, Department of Medical Oncology, BC Cancer and University of British Columbia, Vancouver, BC, Canada
⁸British Columbia Cancer Agency, Vancouver, BC, Canada
⁹BC Cancer Centre for Lymphoid Cancer and Department of Pathology and Laboratory Medicine, Vancouver, BC, Canada
¹⁰Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada

Donnacha Fitzgerald, BPharm^1,2,3*, Tobias Roider, MD^3,4,5*, Marc-A. Baertsch, MD^6,7*, Harald Vöhringer, PhD^1,4*, Mareike Knoll^8*, Bettina Budeus, PhD^9*, Artur Kibler, PhD^9*, Anna Mathioudaki, MSc^10,11*, Léandra Caillé^5*, Linsha Li, MSc^4*, Johannes Mammen^1,3*, Marc Seifert, PhD^12*, Wolfgang Huber, PhD^3,4* and Sascha Dietrich, M.D.^3,4,5

¹Department of Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Heidelberg, Germany
²Molecular Medicine Partnership Unit, European Molecular Biology Laboratory (EMBL), Heidelberg, Germany
³Molecular Medicine Partnership Unit (MMPU), Heidelberg, Germany
⁴European Molecular Biology Laboratory (EMBL), Heidelberg, Germany
⁵Internal Medicine V - Hematology, Oncology & Rheumatology, University Hospital Heidelberg, Heidelberg, Germany
⁶Department of Hematology, Oncology and Rheumatology, University Hospital Heidelberg, Heidelberg, Germany
⁷School of Medicine, Department of Microbiology and Immunology, Stanford University, Stanford, CA
⁸Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany
⁹Institute of Cellbiology, Essen, DEU
¹⁰Structural and Computational Biology Unit, EMBL, Heidelberg, Germany
¹¹Department of Medicine V, Hematology, Oncology and Rheumatology,, University Hospital Heidelberg, Heidelberg, Germany
¹²Group Molecular Genetics, Essen University Hospital, Essen, Germany

Hannah Dorando, BS^1*, Jared Andrews, PhD^1*, Nicholas Borcherding, MD, PhD^2*, Chaz Quinn, MS^1*, Jennifer Schmidt, MS^1*, Jahnavi Aluri, PhD^3*, Megan Cooper, MD, PhD^4*, Amy C.M. Musiek, MD^5*, Neha Mehta-Shah, MD, MSCI⁶ and Jacqueline E. Payton, MD, PhD¹

¹Department of Pathology and Immunology, Washington University School of Medicine, Saint Louis, MO
²Washington University School of Medicine, ST LOUIS, MO
³Washington University School of Medicine, Saint Louis, MO
⁴Department of Pediatrics, Washington University School of Medicine, Saint Louis, MO
⁵Department of Medicine, Division of Dermatology, Washington University School of Medicine, Saint Louis, MO
⁶Division of Oncology, Washington University School of Medicine, St. Louis, MO

Makoto Yamagishi, PhD^1*, Yuta Kuze^2*, Makoto Nakashima, Ph.D.^1*, Seiichiro Kobayashi, M.D., Ph.D.³, Satoko Morishima, M.D., Ph.D.^4*, Toyotaka Kawamata, M.D., Ph.D.^5*, Junya Makiyama, M.D., Ph.D.^6*, Kazumi Abe^2*, Kiyomi Imamura^2*, Eri Watanabe^7*, Kazumi Tsuchiya^7*, Isao Yasumatsu^8*, Gensuke Takayama, PhD^9*, Kazumi Ito, D.V.M., Ph.D.^10*, Yasuhito Nannya, M.D., Ph.D.⁵, Arinobu Tojo, M.D., Ph.D.¹¹, Toshiki Watanabe, M.D., Ph.D.^12*, Shinji Tsutsumi, Ph.D.^10*, Yutaka Suzuki, Ph.D.^13* and Kaoru Uchimaru, M.D., Ph.D.^1*

¹Laboratory of Tumor Cell Biology, Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences, The University of Tokyo, Tokyo, Japan
²Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences, The University of Tokyo, Chiba, Japan
³Department of Hematology, Kanto Rosai Hospital, Kanagawa, Japan
⁴Division of Endocrinology, Diabetes and Metabolism, Hematology and Rheumatology, Second Department of Internal Medicine, Graduate School of Medicine, University of the Ryukyus, Okinawa, Japan
⁵Department of Hematology/Oncology, IMSUT Hospital, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan
⁶Department of Hematology, Sasebo City General Hospital, Nagasaki, Japan
⁷IMSUT Clinical Flow Cytometry Laboratory, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan
⁸Organic Synthesis Department, Daiichi Sankyo RD Novare Co., Ltd., Tokyo, Japan
⁹Translational Science I, Daiichi Sankyo Co., Ltd., Shinagawa-Ku, Japan
¹⁰Translational Science I, Daiichi Sankyo Co., Ltd., Tokyo, Japan
¹¹Tokyo Medical and Dental University, Tokyo, Japan
¹²Department of Advanced Medical Innovation, St. Marianna University Graduate School of Medicine, Kanagawa, Japan
¹³Laboratory of Systems Genomics, Department of Computational Biology and Medical Sciences, The University of Tokyo, Tokyo, Japan

Marine Baron^1,2*, Karim Labreche, PhD^3*, Amira Bouzidi, PhD^4*, Marianne Veyri^5*, Nathalie Désiré^3*, Véronique Leblond, MD, PhD^1*, Florence Coulet^6*, Pierre-Yves Boelle^3*, Fatou Seck Thiam^3*, Damien Roos-Weil, MD, PhD^1*, Frédéric Charlotte, MD^7*, Frederic Davi, MD, PhD^8*, Elsa Poullot, MD^9*, Alice Rousseau^2*, Corinne Haioun, MD, PhD¹⁰, Jean-Philippe Spano, MD, PhD^5*, Brigitte Autran, MD, PhD^2*, Choquet Sylvain, MD^11* and Amélie Guihot, MD, PhD^2*

¹Department of Clinical Haematology, Sorbonne Université, AP-HP, Pitié-Salpêtrière Hospital, Paris, France
²Department of Immunology, Sorbonne Université, INSERM U1135, CIMI, AP-HP, Pitié-Salpêtrière Hospital, Paris, France
³Department of Bioinformatics, Sorbonne Université, INSERM, Pierre Louis Institute of Epidemiology and Public Health, Paris, France
⁴Department of Endocrine Biochemistry and Oncology, Sorbonne Université, INSERM, Research Unit on Cardiovascular and Metabolic Disease UMR ICAN, AP-HP, Pitié-Salpêtrière Hospital, Paris, France
⁵Department of Clinical Oncology, Sorbonne Université, AP-HP, Pitié-Salpêtrière Hospital, Paris, France
⁶Department of medical genetics, Sorbonne Université, INSERM, Saint-Antoine Research Center, Microsatellites Instability and Cancer, CRSA, AP-HP, Pitié-Salpêtrière Hospital, Paris, France
⁷Department of Pathology, Sorbonne Université, APHP, Pitié-Salpêtrière Hospital, Paris, France
⁸Department of Biological Haematology, Sorbonne Université, INSERM, Centre de recherche des Cordeliers, AP-HP, Pitié-Salpêtrière Hospital, Paris, FRA
⁹Department of Pathology, Henri Mondor Hospital, Créteil, France
¹⁰Lymphoid Malignancies Unit, Henri Mondor Hospital, Créteil, France
¹¹Department of Clinical Hematology, Sorbonne Université, AP-HP, Pitié-Salpêtrière Hospital, Paris, France